Literature DB >> 32677986

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Tiantian Guo1, Denghong Zhang1, Yuzhe Zeng2, Timothy Y Huang3, Huaxi Xu4, Yingjun Zhao5.   

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disorder seen in age-dependent dementia. There is currently no effective treatment for AD, which may be attributed in part to lack of a clear underlying mechanism. Studies within the last few decades provide growing evidence for a central role of amyloid β (Aβ) and tau, as well as glial contributions to various molecular and cellular pathways in AD pathogenesis. Herein, we review recent progress with respect to Aβ- and tau-associated mechanisms, and discuss glial dysfunction in AD with emphasis on neuronal and glial receptors that mediate Aβ-induced toxicity. We also discuss other critical factors that may affect AD pathogenesis, including genetics, aging, variables related to environment, lifestyle habits, and describe the potential role of apolipoprotein E (APOE), viral and bacterial infection, sleep, and microbiota. Although we have gained much towards understanding various aspects underlying this devastating neurodegenerative disorder, greater commitment towards research in molecular mechanism, diagnostics and treatment will be needed in future AD research.

Entities:  

Keywords:  Alzheimer’s disease; Astrocyte; Aβ; Microglia; Tau

Mesh:

Substances:

Year:  2020        PMID: 32677986      PMCID: PMC7364557          DOI: 10.1186/s13024-020-00391-7

Source DB:  PubMed          Journal:  Mol Neurodegener        ISSN: 1750-1326            Impact factor:   14.195


  646 in total

1.  Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.

Authors:  P M Stanford; G M Halliday; W S Brooks; J B Kwok; C E Storey; H Creasey; J G Morris; M J Fulham; P R Schofield
Journal:  Brain       Date:  2000-05       Impact factor: 13.501

2.  Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.

Authors:  Sarah K Kaufman; David W Sanders; Talitha L Thomas; Allison J Ruchinskas; Jaime Vaquer-Alicea; Apurwa M Sharma; Timothy M Miller; Marc I Diamond
Journal:  Neuron       Date:  2016-10-27       Impact factor: 17.173

Review 3.  Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain.

Authors:  Nona Abolhassani; Julio Leon; Zijing Sheng; Sugako Oka; Hideomi Hamasaki; Toru Iwaki; Yusaku Nakabeppu
Journal:  Mech Ageing Dev       Date:  2016-05-24       Impact factor: 5.432

4.  Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain.

Authors:  Mark A Lovell; Sony Soman; Melissa A Bradley
Journal:  Mech Ageing Dev       Date:  2011-08-22       Impact factor: 5.432

5.  Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A₂ activation in astrocytes and cerebral endothelial cells.

Authors:  S Askarova; X Yang; W Sheng; G Y Sun; J C-M Lee
Journal:  Neuroscience       Date:  2011-09-28       Impact factor: 3.590

Review 6.  Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.

Authors:  Mitsuru Shinohara; Masaya Tachibana; Takahisa Kanekiyo; Guojun Bu
Journal:  J Lipid Res       Date:  2017-04-04       Impact factor: 5.922

7.  Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A.

Authors:  G Drewes; E M Mandelkow; K Baumann; J Goris; W Merlevede; E Mandelkow
Journal:  FEBS Lett       Date:  1993-12-28       Impact factor: 4.124

8.  TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers.

Authors:  Jorge L Del-Aguila; Bruno A Benitez; Zeran Li; Umber Dube; Kathie A Mihindukulasuriya; John P Budde; Fabiana H G Farias; Maria Victoria Fernández; Laura Ibanez; Shan Jiang; Richard J Perrin; Nigel J Cairns; John C Morris; Oscar Harari; Carlos Cruchaga
Journal:  Mol Neurodegener       Date:  2019-05-08       Impact factor: 14.195

9.  Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration.

Authors:  Amit U Joshi; Paras S Minhas; Shane A Liddelow; Bereketeab Haileselassie; Katrin I Andreasson; Gerald W Dorn; Daria Mochly-Rosen
Journal:  Nat Neurosci       Date:  2019-09-23       Impact factor: 24.884

10.  Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody.

Authors:  Veronika Logovinsky; Andrew Satlin; Robert Lai; Chad Swanson; June Kaplow; Gunilla Osswald; Hans Basun; Lars Lannfelt
Journal:  Alzheimers Res Ther       Date:  2016-04-06       Impact factor: 8.823

View more
  125 in total

Review 1.  Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety.

Authors:  Md Abdul Hannan; Md Ataur Rahman; Abdullah Al Mamun Sohag; Md Jamal Uddin; Raju Dash; Mahmudul Hasan Sikder; Md Saidur Rahman; Binod Timalsina; Yeasmin Akter Munni; Partha Protim Sarker; Mahboob Alam; Md Mohibbullah; Md Nazmul Haque; Israt Jahan; Md Tahmeed Hossain; Tania Afrin; Md Mahbubur Rahman; Md Tahjib-Ul-Arif; Sarmistha Mitra; Diyah Fatimah Oktaviani; Md Kawsar Khan; Ho Jin Choi; Il Soo Moon; Bonglee Kim
Journal:  Nutrients       Date:  2021-05-24       Impact factor: 5.717

2.  RPS23RG1 modulates tau phosphorylation and axon outgrowth through regulating p35 proteasomal degradation.

Authors:  Dongdong Zhao; Yunqiang Zhou; Yuanhui Huo; Jian Meng; Xiaoxia Xiao; Linkun Han; Xian Zhang; Hong Luo; Dan Can; Hao Sun; Timothy Y Huang; Xin Wang; Jie Zhang; Fa-Rong Liu; Huaxi Xu; Yun-Wu Zhang
Journal:  Cell Death Differ       Date:  2020-09-09       Impact factor: 15.828

Review 3.  Alzheimer's pathogenic mechanisms and underlying sex difference.

Authors:  Donghui Zhu; Axel Montagne; Zhen Zhao
Journal:  Cell Mol Life Sci       Date:  2021-04-12       Impact factor: 9.261

Review 4.  The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease.

Authors:  Qing Xia; XinYu Yang; JiaBin Shi; ZiJie Liu; YaHui Peng; WenJing Wang; BoWen Li; Yu Zhao; JiaYing Xiao; Lei Huang; DaYong Wang; Xu Gao
Journal:  Mol Neurobiol       Date:  2021-04-29       Impact factor: 5.590

Review 5.  Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease.

Authors:  Tamas Fulop; Shreyansh Tripathi; Serafim Rodrigues; Mathieu Desroches; Ton Bunt; Arnold Eiser; Francois Bernier; Pascale B Beauregard; Annelise E Barron; Abdelouahed Khalil; Adam Plotka; Katsuiku Hirokawa; Anis Larbi; Christian Bocti; Benoit Laurent; Eric H Frost; Jacek M Witkowski
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-04       Impact factor: 2.570

Review 6.  Blood-Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration.

Authors:  Alla B Salmina; Ekaterina V Kharitonova; Yana V Gorina; Elena A Teplyashina; Natalia A Malinovskaya; Elena D Khilazheva; Angelina I Mosyagina; Andrey V Morgun; Anton N Shuvaev; Vladimir V Salmin; Olga L Lopatina; Yulia K Komleva
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 7.  Targeting Common Signaling Pathways for the Treatment of Stroke and Alzheimer's: a Comprehensive Review.

Authors:  Sedigheh Eskandari; Soraya Sajadimajd; Loghman Alaei; Zhaleh Soheilikhah; Hossein Derakhshankhah; Gholamreza Bahrami
Journal:  Neurotox Res       Date:  2021-06-25       Impact factor: 3.911

Review 8.  Traumatic Brain Injury and Risk of Neurodegenerative Disorder.

Authors:  Benjamin L Brett; Raquel C Gardner; Jonathan Godbout; Kristen Dams-O'Connor; C Dirk Keene
Journal:  Biol Psychiatry       Date:  2021-06-02       Impact factor: 13.382

9.  Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer's Disease in a Central European Population.

Authors:  Vladimir J Balcar; Tomáš Zeman; Vladimír Janout; Jana Janoutová; Jan Lochman; Omar Šerý
Journal:  Neurochem Res       Date:  2020-11-18       Impact factor: 3.996

10.  Cerebrospinal Fluid of Patients With Alzheimer's Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles.

Authors:  Janine Utz; Judith Berner; Luis Enrique Muñoz; Timo Jan Oberstein; Johannes Kornhuber; Martin Herrmann; Juan Manuel Maler; Philipp Spitzer
Journal:  Front Aging Neurosci       Date:  2021-07-06       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.